FILTER

Refine your search with the following facets to narrow down your results.

8,350 Current news from the ressort business & finance

Sigma-Aldrich and MedAssets Announce Agreement

23-Sep-2005 - Sigma-Aldrich announced an agreement with MedAssets Supply Chain Systems to distribute its MedBasics products to MedAssets' customer base. Established in 2004, the MedBasics product line consists of more than 3,000 of the most popular products used by medical testing laboratories on a frequent ...

bases cell cultures histology +7

Air Products to provide liquefaction process technology and equipment for new LNG plant in yemen

22-Sep-2005 - Air Products announced that it received an order for two main cryogenic heat exchangers from Yemen LNG Company Ltd. for two liquefied natural gas (LNG) process trains to be built in Bal-Haf, Republic of Yemen. The two heat exchangers will be part of Yemen's first-ever LNG plant. "Air Products ...

Air Products gas heat exchangers

KemFine acquires Avecia Fine Chemicals Limited

21-Sep-2005 - KemFine Limited, Finland and Avecia Group Plc announced that KemFine has acquired Avecia Fine Chemicals Limited based in Grangemouth, Scotland. Financial details were not disclosed. The combined business will create a major new force in the global fine chemical sector, with a leading position in ...

agrochemicals fine chemicals Finland +2

Thermo to Sell Point of Care and Rapid Diagnostics Business

21-Sep-2005 - Thermo Electron Corporation announced that it has entered into a definitive agreement to sell its Point of Care and Rapid Diagnostics business, formally known as Thermo Biostar, to Inverness Medical Innovations for $52.5 million in cash. The closing of the acquisition is subject to Inverness ...

diagnostics divestitures infectious diseases +4

LGC and Forensic Alliance Limited join forensic operations

20-Sep-2005 - LGC has announced its acquisition of Forensic Alliance Limited (FAL) - the UK's largest private sector provider of forensic science services to investigators and the courts. The combined forensic capabilities of LGC and FAL extend the breadth and depth of cutting-edge scientific solutions ...

laboratories LGC pathology +2

Univar helps specialised coatings manufacturer Castellano reshape its product portfolio to eliminate 'risk provisions'

20-Sep-2005 - Univar N.V. continues to deliver technical service to industry customers assisting Castellano, a privately owned, Marseille-based French manufacturer of highly specialised marine and aviation paint systems, to overcome the technical challenge involved in reshaping and re-supplying its product ...

chemicals coatings paints +3

Altachem Pharma Ltd. completes collapse of a Chinese subsidiary

19-Sep-2005 - Altachem Pharma Ltd. announced that it has received notification that all of the necessary approvals have been received from the Chinese government to collapse the Company's wholly-owned subsidiary, Shanghai Altachem Pharma Biotechnology Ltd ("SACP") and to repatriate all assets back to Canada. ...

biotechnology China disinfectants

Zentiva to Acquire Control of Sicomed, Romania's Leading Generics Company

19-Sep-2005 - Zentiva N.V. announced the signing of an agreement for the acquisition of 51% of S.C. Sicomed S.A., a generics company in Romania via the acquisition of Venoma Holdings Limited for US$ 102 million in cash. Venoma is a holding company which owns a 51% interest in Sicomed, which is listed on the ...

anti-infectives generics respiratory diseases +1

Pfizer Completes Acquisition of Vicuron Pharmaceuticals

16-Sep-2005 - Pfizer Inc completed its acquisition of Vicuron Pharmaceuticals Inc., a biopharmaceutical company focused on the development of novel anti-infectives for both hospital-based and community-acquired infections. In connection with the closing, shares of Vicuron common stock have been delisted from ...

anti-infectives fungal infections Pfizer

Merck KGaA Purchases Spanish Pharmaceutical Business Prasfarma

15-Sep-2005 - Merck KGaA announced that its Spanish subsidiary Merck Genericos SL has purchased the pharmaceutical business of Prasfarma from Almirall Prodesfarma SA, for EUR 20 million, including inventories and other working capital. "A key element of our strategy in Europe is to expand in fast growing ...

Merck oncology Spain